Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
ASSETS    
Cash and cash equivalents $ 63,615 $ 190,081
Investments, available-for-sale (amortized cost of $133,549 and $32,349, respectively) 128,269 32,332
Receivables 13,710 3,896
Prepaid and other current assets 7,263 874
Total current assets 212,857 227,183
Operating lease right-of-use assets 15,937 16,093
Property, plant, and equipment, net of accumulated depreciation of $1,055 and $707, respectively 4,636 4,102
Goodwill 1,111 4,204
Intangible assets, net of accumulated amortization of $37 and $27, respectively 4,063 147
Restricted cash 1,500 1,500
Other long-term assets 16,063 4,219
Total assets 256,167 257,448
LIABILITIES AND SHAREHOLDERS’ EQUITY    
Trade payables 2,294 4,645
Contract liabilities 7,866 513
Contract loss provisions 34,188 397
Accrued expenses and other current liabilities 6,266 6,974
Total current liabilities 50,614 12,529
Debt, net of current portion 31 35
Operating lease liabilities, net of current portion 15,091 14,183
Warrant liability 10,537 14,563
Other long-term liabilities 2,591 2,080
Total liabilities 78,864 43,390
Commitments and contingencies (see Note 9)
Shareholders’ equity    
Common stock, $0.0001 par value; 500,000,000 shares authorized; 186,121,281 shares issued and outstanding (excluding restricted shares of 399,513) as of March 31, 2022 and 183,367,037 shares issued and outstanding (excluding restricted shares of 481,301) as of December 31, 2021 19 18
Additional paid-in capital 403,216 380,624
Accumulated other comprehensive loss (384) (4)
Accumulated deficit (225,548) (166,580)
Total shareholders’ equity 177,303 214,058
Total liabilities and shareholders’ equity $ 256,167 $ 257,448